Reactive arthritis laboratory findings

Jump to navigation Jump to search

Reactive arthritis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Reactive arthritis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Reactive arthritis laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Reactive arthritis laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Reactive arthritis laboratory findings

CDC on Reactive arthritis laboratory findings

Reactive arthritis laboratory findings in the news

Blogs onReactive arthritis laboratory findings

Directions to Hospitals Treating Reactive arthritis

Risk calculators and risk factors forReactive arthritis laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Laboratory findings consistent with the diagnosis of reactive arthritis include elevated erythrocyte sedimentation rate (ESR), elevated C-reactive protein (CRP), and elevated total leukocyte count (TLC) showing increased polymorphonuclear cells (PMNs). Synovial fluid or synovial membrane biopsy for detection of bacterial DNA by polymerase chain reaction (PCR) or immunofluorescence microscopy.

Laboratory Findings

Laboratory findings consistent with the diagnosis of reactive arthritis include:[1][2]

References

  1. Colmegna I, Cuchacovich R, Espinoza LR (April 2004). "HLA-B27-associated reactive arthritis: pathogenetic and clinical considerations". Clin. Microbiol. Rev. 17 (2): 348–69. PMC 387405. PMID 15084505.
  2. Locht H, Peen E, Skogh T (December 1995). "Antineutrophil cytoplasmic antibodies in reactive arthritis". J. Rheumatol. 22 (12): 2304–6. PMID 8835566.


Template:WikiDoc Sources